Effectiveness of whole exome sequencing analyses in the molecular diagnosis of osteogenesis imperfecta.

Autor:	Evin F; Pediatric Endocrinology, Çiğli Training and Research Hospital, Bakırçay University, Izmir, Türkiye., Atik T; Department of Pediatric Genetics, Faculty of Medicine, Ege University, Izmir, Türkiye., Onay H; Multigen Genetic Diseases Diagnosis Center, Izmir, Türkiye., Goksen D; Department of Pediatric Endocrinology and Diabetes, Faculty of Medicine, Ege University, Izmir, Türkiye., Darcan S; Department of Pediatric Endocrinology and Diabetes, Faculty of Medicine, Ege University, Izmir, Türkiye., Cogulu O; Department of Pediatric Genetics, Faculty of Medicine, Ege University, Izmir, Türkiye., Ozen S; Department of Pediatric Endocrinology and Diabetes, Faculty of Medicine, Ege University, Izmir, Türkiye.
Jazyk:	angličtina
Zdroj:	Journal of pediatric endocrinology & metabolism : JPEM [J Pediatr Endocrinol Metab] 2024 Jul 03; Vol. 37 (8), pp. 693-700. Date of Electronic Publication: 2024 Jul 03 (Print Publication: 2024).
DOI:	10.1515/jpem-2024-0058
Abstrakt:	Objectives: Osteogenesis imperfecta (OI) is a group of phenotypically and genetically heterogeneous connective tissue disorders that share similar skeletal anomalies causing bone fragility and deformation. This study aimed to investigate the molecular genetic etiology and to determine the relationship between genotype and phenotype in OI patients with whole exome sequencing (WES). Methods: Multiplex-Ligation dependent Probe Amplification (MLPA) analysis of COL1A1 and COL1A2 and WES were performed on cases between the ages of 0 and 18 whose genetic etiology could not be determined before using a targeted next-generation sequencing panel, including 13 genes ( COL1A1 , COL1A2 , IFITM5 , SERPINF1 , CRTAP , P3H1 , PPIB , SERPINH1 , FKBP10 , SP7 , BMP1 , MBTPS2 , PLOD2 ) responsible for OI. Results: Twelve patients (female/male: 4/8) from 10 different families were included in the study. In 6 (50 %) families, consanguineous marriage was noted. The clinical typing based on Sillence classification; 3 (25 %) patients were considered to be type I, 7 (58.3 %) type III, and 2 (16.7 %) type IV. Deletion/duplication wasn't detected in the COL1A1 and COL1A2 genes in the MLPA analysis of the patients. Twelve patients were molecularly analyzed by WES, and in 6 (50 %) of them, a disease-causing variant in three different genes ( FKBP10 , P3H1 , and WNT1 ) was identified. Two (33.3 %) detected variants in all genes have not been previously reported in the literature and were considered deleterious based on prediction tools. In 6 cases, no variants were detected in disease-causing genes. Conclusions: This study demonstrates rare OI types' clinical and molecular features; genetic etiology was determined in 6 (50 %) 12 patients with the WES analysis. In addition, two variants in OI genes have been identified, contributing to the literature. (© 2024 Walter de Gruyter GmbH, Berlin/Boston.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu